clinical dextran derivatives in which from 5 to 50 % of the d-glucose units were oxidized acted as potent and specific enzyme-inhibitors , as did 10 % -oxidized derivatives of dextran fractions ranging in mol . wt . from 10 ( 4 ) to 2 x 10 ( 6 ) .
C0011806
dextran derivatives
C0086140
dextran